| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/08/2010 | US20100173342 Biomarker and Method for Determining an Oxidative Stress Level |
| 07/08/2010 | US20100173341 Apoptosis-based evaluation of chemosensitivity in cancer patients |
| 07/08/2010 | US20100173340 Use of hematopoietic growth factor inducible neurokinin-1 (hgfin) as a novel biomarker |
| 07/08/2010 | US20100173339 Platelet activation markers as indicators for anti-platelet therapy |
| 07/08/2010 | US20100173338 Biomarkers for Cancer Sensitivity and Uses Thereof |
| 07/08/2010 | US20100173337 Quantification of non-reducing end glycan residual compounds |
| 07/08/2010 | US20100173336 Methods for assessment of cardiovascular disease risk |
| 07/08/2010 | US20100173335 Fast Microbiological Analysis Device And Method |
| 07/08/2010 | US20100173333 Method of screening candidate compounds for susceptibility to biliary excretion |
| 07/08/2010 | US20100173325 Composition and Method for Analysis of Target Analytes |
| 07/08/2010 | US20100173320 Methods for Detecting Nucleic Acids Indicative of Cancer |
| 07/08/2010 | US20100173319 Compositions and methods for cancer diagnosis and therapy |
| 07/08/2010 | US20100173318 Method and system for modeling cellular metabolism |
| 07/08/2010 | US20100173317 Method for diagnosing non-small cell lung cancer |
| 07/08/2010 | US20100173316 Probe, probe set, probe carrier, and testing method |
| 07/08/2010 | US20100173315 Assay Particles and Methods of Use |
| 07/08/2010 | US20100173314 Diagnostic methods using tenascin-w compositions |
| 07/08/2010 | US20100173313 Biomarkers of inflammation |
| 07/08/2010 | US20100173312 Genetic lesion associated with cancer |
| 07/08/2010 | US20100173311 Nucleic acid amplification with allele-specific suppression of sequence variants |
| 07/08/2010 | US20100173310 Microchip large-volume pcr with integrated real-time ce detection |
| 07/08/2010 | US20100173309 Situ methods for gene mapping and haplotyping |
| 07/08/2010 | US20100173308 Systems for genome selection |
| 07/08/2010 | US20100173307 Nucleic acid modules for expression and tagging of membrane proteins and methods of use |
| 07/08/2010 | US20100173306 Method for detecting g-quadruplex, method for detecting g-quadruplex-forming dna and method for determining telomerase activity |
| 07/08/2010 | US20100173305 Compositions, kits and related methods for the detection and/or monitoring of listeria |
| 07/08/2010 | US20100173304 Method of dna sequencing |
| 07/08/2010 | US20100173303 Multibase delivery for long reads in sequencing by synthesis protocols |
| 07/08/2010 | US20100173302 Positive control proteins for glucose transporter proteins and processes for the generation of such positive control proteins |
| 07/08/2010 | US20100173301 Prognostic tools to predict the efficacy of drug treatment targeting chromatin dna or enzymes acting on dna |
| 07/08/2010 | US20100173300 Noncontact stirring method, noncontact stirring apparatus, method and apparatus for reacting nucleic acid hybridization using the apparatus, method for detecting nucleic acid in sample, apparatus for detecting nucleic acid, method for detecting antibody in sample, apparatus for detecting antibody |
| 07/08/2010 | US20100173299 Mutant nucleic acid related to chronic myeloproliferative disorder and method of evaluating chronic myeloproliferative disorder |
| 07/08/2010 | US20100173298 Hcv gene |
| 07/08/2010 | US20100173297 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/08/2010 | US20100173296 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 07/08/2010 | US20100173295 Fixation of a biological material |
| 07/08/2010 | US20100173294 Diagnostic test for susceptibility to b-raf kinase inhibitors |
| 07/08/2010 | US20100173293 High Density Sequence Detection Methods |
| 07/08/2010 | US20100173292 NOVEL GPIIIa GENE |
| 07/08/2010 | US20100173291 Methods and kits for detecting fetal cells in the maternal blood |
| 07/08/2010 | US20100173290 Monitoring of enzymatic processes by using magnetizable or magnetic objects as labels |
| 07/08/2010 | US20100173289 Methods for Assessing Cancer Susceptibility to Carcinogens in Tobacco Products |
| 07/08/2010 | US20100173288 Serum/plasma micronas and uses thereof |
| 07/08/2010 | US20100173287 Method of analyzing nucleic acid |
| 07/08/2010 | US20100173286 Mutant Cells Suitable for Recombinant Polypeptide Production |
| 07/08/2010 | US20100173285 Methods and Compositions for Detecting a Drug Resistant Egfr Mutant |
| 07/08/2010 | US20100173284 Method for Detection of HCV at the Real Time PCR with Intercalating Dye |
| 07/08/2010 | US20100173283 Method of predicting potential severity of hepatitis e, probe sets, and primer sets |
| 07/08/2010 | US20100173282 Mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance |
| 07/08/2010 | US20100173281 HCV NS3 protease replicon shuttle vectors |
| 07/08/2010 | US20100173280 Systems for Detection and Production of Respiratory, Herpes and Enteric Viruses |
| 07/08/2010 | US20100173279 Detection using primers to repetitive dna and transcription-based amplification thereby |
| 07/08/2010 | US20100173024 Methods and compositions for altering health, wellbeing, and lifespan |
| 07/08/2010 | US20100172943 Peptide nanoparticles and uses therefor |
| 07/08/2010 | US20100172933 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against lieshmaniasis |
| 07/08/2010 | US20100172931 Pharmaceutical Composition Containing the NMB1796 Protein |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172917 Binding molecules against SARS-coronavirus and uses thereof |
| 07/08/2010 | US20100172901 Polymorphisms in the EGFR Pathway as Markers for Cancer Treatment |
| 07/08/2010 | US20100172881 Use of tailored recombinases for the treatment of retroviral infections |
| 07/08/2010 | US20100172880 Dna methylation markers based on epigenetic stem cell signatures in cancer |
| 07/08/2010 | US20100172878 Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes |
| 07/08/2010 | US20100172874 Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder |
| 07/08/2010 | US20100172870 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 07/08/2010 | US20100172838 Endometrial biomarkers |
| 07/08/2010 | US20100172834 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 07/08/2010 | US20100172833 Methods and compositions for diagnosing hepatocellular carcinoma |
| 07/08/2010 | US20100172832 Diagnosis and treatment of malignant neoplasms |
| 07/08/2010 | US20100171950 Methods for uniform metal impregnation into a nanoporous material |
| 07/08/2010 | US20100170793 Small Volume In Vitro Analyte Sensor and Methods of Making |
| 07/08/2010 | DE19846432B4 Verwendung von Hopfenextrakt als Antibiotikum Use of hops extract as an antibiotic |
| 07/08/2010 | DE102010004428A1 Untersuchungsverfahren/Screeningverfahren unter Einbeziehung lebender Zellen oder lebender Zellsysteme Investigation procedure / screening process involving living cells or living cellular systems |
| 07/08/2010 | DE102008063290A1 Determining increased blood pressure over a previous period on blood samples comprises determining increased and/or reduced occurrence of specific marker proteins or corresponding RNA protein containing blood components in peripheral blood |
| 07/08/2010 | CA2750155A1 Serum markers predicting clinical response to anti-tnf.alpha. antibodiesin patients with ankylosing spondylitis |
| 07/08/2010 | CA2748759A1 Uses of bortezomib in predicting survival in multiple myeloma patients |
| 07/08/2010 | CA2747676A1 Transgenic sugar beet event gm rz13 |
| 07/08/2010 | CA2747026A1 Methods, compositions, and kits for detecting allelic variants |
| 07/08/2010 | CA2746953A1 Corn event 5307 |
| 07/08/2010 | CA2746539A1 Compositions, kits and related methods for the detection and/or monitoring of listeria |
| 07/08/2010 | CA2746506A1 Method of modulating hsf-1 |
| 07/08/2010 | CA2743704A1 Methods and compositions for testing and breeding cattle for improved fertility and embryonic survival |
| 07/08/2010 | CA2742377A1 Low total salt reagent compositions and systems for biosensors |
| 07/08/2010 | CA2741596A1 Primers and probes for detecting hepatitis c virus |
| 07/07/2010 | EP2204752A1 System and method for consensus-calling with per-base quality values for sample assemblies |
| 07/07/2010 | EP2204653A1 Diagnosticum for determining the presence of total endotoxin (lipopolysaccharide-lps) of gram-negative bacteria and also the genus and type of gram-negative bacteria producing endotoxin, method for producing said diagnosticum and a set |
| 07/07/2010 | EP2204643A1 Cell analysis apparatus and cell analysis method |
| 07/07/2010 | EP2204458A1 Concatameric ligation products: compositions, methods and kits for same |
| 07/07/2010 | EP2204457A2 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of MRD in leukemia |
| 07/07/2010 | EP2204456A1 Soluble analyte detection and amplification |
| 07/07/2010 | EP2204455A1 Diagnostic assay for thrombin-activatable fibrinolysis inhibitor (TAFI) |
| 07/07/2010 | EP2204454A1 Predicting treatment response in cancer subjects |
| 07/07/2010 | EP2204449A2 Nucleotide sequences encoding enzymes in biosynthesis of dihydroartemisinic acid |
| 07/07/2010 | EP2204448A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 07/07/2010 | EP2204447A2 Method for generating diversity |
| 07/07/2010 | EP2204445A1 Methods and kit for primer-dependent amplification heterologous viral, eukaryotic and prokaryotic RNA |
| 07/07/2010 | EP2204376A2 Novel therapeutic targets in cancer |
| 07/07/2010 | EP2204371A1 Fluorescent molecule |
| 07/07/2010 | EP2204177A1 Cancer marker and therapeutic agent for cancer |
| 07/07/2010 | EP2204086A1 Six row-type barley |
| 07/07/2010 | EP2203571A1 Gene-based algorithmic cancer prognosis and clinical outcome of a patient |